Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Carcinoma × atezolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Small Cell Lung Carcinoma 2 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Sarcoma, Alveolar Soft Part 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

Pemetrexed 3 Carboplatin 3 durvalumab 2 Cisplatin 2 tremelimumab 1 repotrectinib 1 pralsetinib 1 osimertinib 1 brigatinib 1 atezolizumab 1 Surgical Procedures, Operative 1 Paclitaxel 1 Mitomycin 1 Gemcitabine 1 Crizotinib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02367781 2021-08-09

IMpower130

Hoffmann-La Roche

Phase 3 Completed

723 enrolled 28 charts 1 FDA

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡